{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:02:31Z","timestamp":1793653351075,"version":"4.5.1"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Residual kidney function (RKF) is a key determinant of outcomes in patients undergoing peritoneal dialysis (PD), contributing to solute clearance, volume regulation, reduced inflammation, and improved survival. Nevertheless, RKF commonly declines after PD initiation, often due to potentially modifiable clinical and treatment-related factors. This narrative review summarizes current evidence on the mechanisms underlying RKF loss in PD and evaluates established and emerging strategies to preserve RKF in contemporary practice. Major contributors to RKF decline include hemodynamic instability, cumulative glucose exposure, inflammation and peritonitis, nephrotoxic medications, dialysis-related volume shifts, and kidney disease-specific conditions. Conventional strategies such as incremental and individualized PD prescriptions, use of biocompatible and glucose-sparing solutions, careful volume and blood pressure management, renin\u2013angiotensin\u2013aldosterone system blockade, infection prevention, and tailored management after kidney allograft failure are reviewed. Importantly, current guideline-based strategies largely address these factors in isolation. We propose that RKF preservation should be approached through an integrated, mechanism-based framework, in which cumulative glucose exposure represents a central modifiable mediator linking multiple pathways of kidney injury. In this context, remote monitoring and artificial intelligence-based tools may serve as enabling platforms that integrate longitudinal clinical and treatment data, supporting individualized and proactive care. Preserving RKF should remain a central therapeutic goal in PD, and combining established physiological principles with modern digital technologies may provide a more effective framework for improving long-term patient outcomes.<\/jats:p>","DOI":"10.1093\/ckj\/sfag131","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:34:36Z","timestamp":1777116876000},"source":"Crossref","is-referenced-by-count":5,"title":["Preserving residual kidney function in peritoneal dialysis: from conventional approaches to contemporary practice"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-1048","authenticated-orcid":false,"given":"Haci Hasan","family":"Yeter","sequence":"first","affiliation":[{"name":"Hacettepe University Faculty of Medicine Department of Nephrology, , Sihhiye, Ankara ,","place":["T\u00dcRK\u0130YE"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"2026051313283253200_bib1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2024.2431578","article-title":"Preserving residual kidney function in persons on peritoneal dialysis: the role of pharmacotherapy","volume":"24","author":"Formosa","year":"2025","journal-title":"Expert Opin Drug Saf"},{"key":"2026051313283253200_bib2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0896860819895364","article-title":"International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis","volume":"40","author":"Brown","year":"2020","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/sdi.13129","article-title":"Evolving peritoneal dialysis care in Chinese mainland from 2010 to 2020: comparison data from two surveys","volume":"36","author":"Li","year":"2023","journal-title":"Semin Dial"},{"key":"2026051313283253200_bib4","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.3390\/ijms23094831","article-title":"Fibrosis of peritoneal membrane as target of new therapies in peritoneal dialysis","volume":"23","author":"Masola","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026051313283253200_bib5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/089686080002000410","article-title":"Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it","volume":"20","author":"Singhal","year":"2000","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000503805","article-title":"Rationale and strategies for preserving residual kidney function in dialysis patients","volume":"50","author":"Li","year":"2019","journal-title":"Am J Nephrol"},{"key":"2026051313283253200_bib7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0272-6386(03)00362-7","article-title":"The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2","volume":"41","author":"Termorshuizen","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2026051313283253200_bib8","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2026051313283253200_bib9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","article-title":"Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study","volume":"68","author":"Obi","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026051313283253200_bib10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/ndt\/gfv271","article-title":"The intact nephron hypothesis in reverse: an argument to support incremental dialysis","volume":"30","author":"Golper","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026051313283253200_bib11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.34067\/KID.0006902022","article-title":"Incremental peritoneal dialysis\u2014definition, prescription, and clinical outcomes","volume":"360","author":"Fernandes","year":"2023","journal-title":"Kidney"},{"key":"2026051313283253200_bib12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/ijn.ijn_242_23","article-title":"A review of residual kidney function in peritoneal dialysis patients","volume":"33","author":"Alrowiyti","year":"2023","journal-title":"Indian J Nephrol"},{"key":"2026051313283253200_bib13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/089686080502500311","article-title":"Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis","volume":"25","author":"Font\u00e1n","year":"2005","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3747\/pdi.2013.00075","article-title":"Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis","volume":"35","author":"Szeto","year":"2015","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/089686080302300311","article-title":"Predictors of decline of residual renal function in new peritoneal dialysis patients","volume":"23","author":"Johnson","year":"2003","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib16","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/ndt\/16.11.2240","article-title":"Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis","volume":"16","author":"Chung","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"2026051313283253200_bib17","doi-asserted-by":"publisher","first-page":"1438952","DOI":"10.3389\/fphys.2024.1438952","article-title":"Peritoneal fibrosis: from pathophysiological mechanism to medicine","volume":"15","author":"Kang","year":"2024","journal-title":"Front Physiol"},{"key":"2026051313283253200_bib18","doi-asserted-by":"publisher","first-page":"1635624","DOI":"10.3389\/fphar.2025.1635624","article-title":"Peritoneal dialysis-associated fibrosis: emerging mechanisms and therapeutic opportunities","volume":"16","author":"Prasad","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026051313283253200_bib19","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"26","author":"Htay","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051313283253200_bib20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12882-024-03669-w","article-title":"Comparison of outcomes of incremental vs. standard peritoneal dialysis: a systematic review and meta-analysis","volume":"25","author":"Xu","year":"2024","journal-title":"BMC Nephrol"},{"key":"2026051313283253200_bib21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3747\/pdi.2011.00027","article-title":"Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function","volume":"32","author":"Guest","year":"2012","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib22","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1007\/s11255-024-04077-7","article-title":"Effects of incremental peritoneal dialysis with low glucose-degradation product neutral pH solution on clinical outcomes","volume":"56","author":"Yeter","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"2026051313283253200_bib23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2215\/CJN.00470110","article-title":"Decline in residual renal function in automated compared with continuous ambulatory peritoneal dialysis","volume":"6","author":"Michels","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026051313283253200_bib24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000368933","article-title":"Compared decline of residual kidney function in patients treated with automated peritoneal dialysis and continuous ambulatory peritoneal dialysis: a multicenter study","volume":"128","author":"P\u00e9rez\u00a0Font\u00e1n","year":"2015","journal-title":"Nephron Clin Pract"},{"key":"2026051313283253200_bib25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3747\/pdi.2016.00206","article-title":"Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ trial","volume":"37","author":"Htay","year":"2017","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib26","first-page":"CD006515","article-title":"Automated peritoneal dialysis versus continuous ambulatory peritoneal dialysis for people with kidney failure","volume":"11","author":"Driehuis","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051313283253200_bib27","first-page":"CD006515","article-title":"Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease","volume":"18","author":"Rabindranath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051313283253200_bib28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/life15020279","article-title":"Current progress in peritoneal dialysis: a narrative review of progress in peritoneal dialysis fluid","volume":"15","author":"Hashimoto","year":"2025","journal-title":"Life"},{"key":"2026051313283253200_bib29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3747\/pdi.2015.00090","article-title":"The trio trial\u2013a randomized controlled clinical trial evaluating the effect of a biocompatible peritoneal dialysis solution on residual renal function","volume":"36","author":"Sikaneta","year":"2016","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/aor.14801","article-title":"Oxidative stress reduction by icodextrin-based glucose-free solutions in peritoneal dialysis: support for new promising approaches","volume":"48","author":"Basso","year":"2024","journal-title":"Artif Organs"},{"key":"2026051313283253200_bib31","doi-asserted-by":"publisher","first-page":"e2991","DOI":"10.1097\/MD.0000000000002991","article-title":"Effect of icodextrin solution on the preservation of residual renal function in peritoneal dialysis patients: a randomized controlled study","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026051313283253200_bib32","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051313283253200_bib33","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1007\/s10157-025-02719-3","article-title":"Association between blood pressure and cardiovascular events and mortality in patients on peritoneal dialysis: a systematic review and meta-analysis of observational studies","author":"Bezerra","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"2026051313283253200_bib34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/jcm14010218","article-title":"Resistant and apparently resistant hypertension in peritoneally dialyzed patients","volume":"14","author":"Symonides","year":"2025","journal-title":"J Clin Med"},{"key":"2026051313283253200_bib35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/nep.13885","article-title":"Relationship between sodium removal, hydration and outcomes in peritoneal dialysis patients","volume":"26","author":"Mok","year":"2021","journal-title":"Nephrology"},{"key":"2026051313283253200_bib36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/ndt\/gfv013","article-title":"Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)","volume":"30","author":"Ronco","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026051313283253200_bib37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2215\/CJN.07480618","article-title":"Assessment and management of hypertension among patients on peritoneal dialysis","volume":"14","author":"Vaios","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026051313283253200_bib38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","article-title":"Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis","volume":"59","author":"Medcalf","year":"2001","journal-title":"Kidney Int"},{"key":"2026051313283253200_bib39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/089686080302300406","article-title":"Acute effects of high-dose furosemide on residual renal function in CAPD patients","volume":"23","author":"Van\u00a0Olden","year":"2003","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/089686080802803s35","article-title":"Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients","volume":"28","author":"Liao","year":"2008","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/nep.13751","article-title":"Effect of remote patient management in peritoneal dialysis on haemodynamic and volume control","volume":"25","author":"Yeter","year":"2020","journal-title":"Nephrology"},{"key":"2026051313283253200_bib42","first-page":"CD009120","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients","volume":"2014","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051313283253200_bib43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12882-017-0605-7","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials","volume":"18","author":"Liu","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026051313283253200_bib44","doi-asserted-by":"publisher","first-page":"38334","DOI":"10.1038\/s41598-025-22195-9","article-title":"Dapagliflozin ameliorates high glucose-induced peritoneal fibrosis through downregulation of ENKUR\/PI3K\/AKT signaling pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"2026051313283253200_bib45","doi-asserted-by":"publisher","first-page":"20543581241293500","DOI":"10.1177\/20543581241293500","article-title":"Role of SGLT-2 inhibitors in ultrafiltration failure in peritoneal dialysis: a narrative review","volume":"11","author":"Riedl\u00a0Khursigara","year":"2024","journal-title":"Can J Kidney Health Dis"},{"key":"2026051313283253200_bib46","doi-asserted-by":"publisher","first-page":"sfaf350","DOI":"10.1093\/ckj\/sfaf350","article-title":"SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art","volume":"19","author":"Minutolo","year":"2026","journal-title":"Clin Kidney J"},{"key":"2026051313283253200_bib47","doi-asserted-by":"publisher","first-page":"gfag014","DOI":"10.1093\/ndt\/gfag014","article-title":"KDIGO 2026 clinical practice guideline for anemia in chronic kidney disease (CKD): a commentary from the European Renal Best Practice (ERBP)","author":"Del\u00a0Vecchio","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"2026051313283253200_bib48","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Disease","year":"2021","journal-title":"Kidney Int"},{"key":"2026051313283253200_bib49","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug dosing consideration in patients with acute and chronic kidney disease\u2014a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int"},{"key":"2026051313283253200_bib50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/ndt\/gfr274","article-title":"Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function","volume":"27","author":"Badve","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2026051313283253200_bib52","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1053\/ajkd.2003.50129","article-title":"Empirical aminoglycosides for peritonitis do not affect residual renal function","volume":"41","author":"Baker","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2026051313283253200_bib53","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/j.1523-1755.2005.00700.x","article-title":"Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function","volume":"68","author":"Lui","year":"2005","journal-title":"Kidney Int"},{"key":"2026051313283253200_bib54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/08860220903491224","article-title":"Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD","volume":"32","author":"Tokgoz","year":"2010","journal-title":"Ren Fail"},{"key":"2026051313283253200_bib55","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s40620-023-01758-x","article-title":"Dialysis after kidney transplant failure: how to deal with this daunting task?","volume":"36","author":"Tanriover","year":"2023","journal-title":"J Nephrol"},{"key":"2026051313283253200_bib56","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/0886022X.2021.1914659","article-title":"Comparison of outcomes of peritoneal dialysis between patients after failed kidney transplant and transplant-na\u00efve patients: a meta-analysis of observational studies","volume":"43","author":"Meng","year":"2021","journal-title":"Ren Fail"},{"key":"2026051313283253200_bib57","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2215\/CJN.06640810","article-title":"Impact of dialysis modality on survival after kidney transplant failure","volume":"6","author":"Perl","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026051313283253200_bib58","doi-asserted-by":"publisher","first-page":"S537","DOI":"10.1097\/01.tp.0000543384.74406.cb","article-title":"Returning to dialysis after kidney transplant failure. Does the dialysis treatment modality influence the survival prognosis?","volume":"102","author":"Salazar","year":"2018","journal-title":"Transplantation"},{"key":"2026051313283253200_bib59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1525-139X.2005.00100.x","article-title":"Managing the failing allograft","volume":"18","author":"Kendrick","year":"2005","journal-title":"Semin Dial"},{"key":"2026051313283253200_bib60","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/TP.0000000000000426","article-title":"Summary of the British Transplantation Society guidelines for management of the failing kidney transplant","volume":"98","author":"Andrews","year":"2014","journal-title":"Transplantation"},{"key":"2026051313283253200_bib61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1525-139X.2005.18306.x","article-title":"The failed renal transplant: in or out?","volume":"18","author":"Bennett","year":"2005","journal-title":"Semin Dial"},{"key":"2026051313283253200_bib62","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/ajt.16717","article-title":"The failing kidney allograft: a review and recommendations for the care and management of a complex group of patients","volume":"21","author":"Lubetzky","year":"2021","journal-title":"Am J Transplant"},{"key":"2026051313283253200_bib63","doi-asserted-by":"publisher","first-page":"e89001","DOI":"10.1371\/journal.pone.0089001","article-title":"Non-adherence in patients on peritoneal dialysis: a systematic review","volume":"9","author":"Griva","year":"2014","journal-title":"PLoS One"},{"key":"2026051313283253200_bib64","doi-asserted-by":"publisher","first-page":"1108030","DOI":"10.3389\/fneph.2023.1108030","article-title":"The optimization of peritoneal dialysis training in long-term","volume":"3","author":"Gursu","year":"2023","journal-title":"Front Nephrol"},{"key":"2026051313283253200_bib65","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1111\/jocn.15301","article-title":"Psycho-social and educational interventions for enhancing adherence to dialysis in adults with end-stage renal disease: a meta-analysis","volume":"29","author":"Tao","year":"2020","journal-title":"J Clin Nurs"},{"key":"2026051313283253200_bib66","doi-asserted-by":"publisher","first-page":"08968608251386224","DOI":"10.1177\/08968608251386224","article-title":"Frequency of therapy alerts during the first 30 days of automated peritoneal dialysis and its relationship to time on treatment","author":"Conway","year":"2025","journal-title":"Perit Dial Int"},{"key":"2026051313283253200_bib67","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/ndt\/gfae188","article-title":"Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial","volume":"40","author":"Paniagua","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026051313283253200_bib68","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1093\/ckj\/sfab111","article-title":"The utility of remote patient management in peritoneal dialysis","volume":"14","author":"Yeter","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026051313283253200_bib69","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000506699","article-title":"Automated remote monitoring for peritoneal dialysis and its impact on blood pressure","volume":"10","author":"Yeter","year":"2020","journal-title":"Cardiorenal Med"},{"key":"2026051313283253200_bib70","doi-asserted-by":"publisher","first-page":"1681169","DOI":"10.3389\/fnut.2025.1681169","article-title":"Machine learning-based prediction of early-onset peritoneal dialysis-associated peritonitis: the role of the CONUT score","volume":"12","author":"Zhou","year":"2025","journal-title":"Front Nutr"},{"key":"2026051313283253200_bib71","first-page":"1097","article-title":"PD-PREDICT\u201d: a machine learning model for patient survival in peritoneal dialysis","volume":"10","author":"Ali","year":"2025","journal-title":"ASAIO J"},{"key":"2026051313283253200_bib72","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41440-025-02283-z","article-title":"Visit-to-visit blood pressure variability as a prognostic marker in peritoneal dialysis: insights from machine learning-based risk models","volume":"48","author":"Morimoto","year":"2025","journal-title":"Hypertens Res"},{"key":"2026051313283253200_bib73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.ajkd.2020.09.010","article-title":"KDOQI US commentary on the 2020 ISPD practice recommendations for prescribing high-quality goal-directed peritoneal dialysis","volume":"77","author":"Teitelbaum","year":"2021","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag131\/68159306\/sfag131.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag131\/68159306\/sfag131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/5\/sfag131\/68159306\/sfag131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:28:42Z","timestamp":1778693322000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag131\/8662461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag131","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,25]]},"article-number":"sfag131"}}